Roberton D M, Georgiou G M, Ellis W M, Hosking C S
Clin Exp Immunol. 1984 Feb;55(2):444-50.
Seven murine monoclonal antibodies (MoAbs) to antigenic determinants present on human lymphocytes did not promote phagocytosis of allogeneic human lymphocytes by human peripheral blood polymorphonuclear leucocytes (PML). Similarly there was no significant metabolic activation of PML as determined by incorporation of radiolabelled iodide. The opsonic activity of MoAbs was not enhanced by addition of human or rabbit complement nor by the use of sheep anti-mouse IgG, rabbit anti-mouse immunoglobulin or goat anti-mouse immunoglobulin as second antibody. Whole serum from mice immunized with human lymphocytes did not act as an opsonin when tested with human PML. Hyperimmune mouse antiserum to Bordetella pertussis antigen acted only weakly as an opsonin. Human PML may not have an in vivo role in the removal of allogeneic lymphocytes treated with murine anti-lymphocyte MoAbs.
七种针对人淋巴细胞上抗原决定簇的鼠单克隆抗体(MoAbs)不能促进人外周血多形核白细胞(PML)对同种异体人淋巴细胞的吞噬作用。同样,通过放射性标记碘化物的掺入所测定的PML也没有显著的代谢激活。通过添加人或兔补体,或者使用羊抗小鼠IgG、兔抗小鼠免疫球蛋白或山羊抗小鼠免疫球蛋白作为第二抗体,MoAbs的调理活性并未增强。用人淋巴细胞免疫的小鼠的全血清在用人类PML进行测试时不起调理素的作用。针对百日咳博德特氏菌抗原的超免疫小鼠抗血清仅具有微弱的调理素作用。人PML在清除用鼠抗淋巴细胞MoAbs处理的同种异体淋巴细胞方面可能在体内不起作用。